Table 6 Univariate and multivariate analyses of prognostic factors for locoregional recurrence-free survival for patients treated by breast conservation
Univariate analysis | Multivariate analysis a | |||||
---|---|---|---|---|---|---|
N | 10-year LRRFS (%)(IC 95%) | P b | RR (IC 95%) | P c | RR (IC 95%) | |
Age (continuous variable) | 0.0009 | 0.96 (0.94–0.98) | ||||
Age (dummy variable) d | <10−6 | <10−5 | ||||
 >40 | 382 | 77 (72–82) | 1 | 1 | ||
 ⩽40 | 94 | 49 (38–63) | 2.6 (1.8–3.7) | 2.6 (1.7–3.7) | ||
Menopause d | 0.1 | |||||
 No | 353 | 69 (63–74) | 1 | |||
 Yes | 123 | 80 (73–88) | 0.7 (0.4–1.1) | |||
Clinical tumour stage d | 0.81 | |||||
 cT2 | 391 | 72 (67–77) | 1 | |||
 cT3 | 85 | 71 (60–83) | 1.1 (0.7–1.7) | |||
Clinical nodal status d | 0.06 | |||||
 cN0 | 315 | 73 (68–79) | 1 | |||
 cN1 | 161 | 68 (60–77) | 1.4 (1.0–2.1) | |||
Histological type d | 0.12 | |||||
 Ductal | 434 | 72 (68–77) | 1 | |||
 Lobular | 42 | 62 (47–82) | 1.5 (0.9–2.6) | |||
Hormonal receptors d | 0.54 | |||||
 HR+ | 291 | 72 (66–78) | 1 | |||
 HR− | 114 | 68 (59–79) | 1.1 (0.7–1.7) | |||
Histological grade | 0.97 | |||||
 Grade 1 | 71 | 73 (63–85) | 1 | |||
 Grade 2 | 215 | 70 (63–77) | 1.0 (0.6–1.6) | |||
 Grade 3 | 156 | 72 (64–81) | 0.9 (0.5–1.6) | |||
Mitotic index | 0.72 | |||||
 Grade 1 | 110 | 71 (62–83) | 1 | |||
 Grade 2 | 125 | 72 (64–82) | 1.1 (0.7–1.8) | |||
 Grade 3 | 195 | 70 (63–78) | 1.2 (0.8–1.9) | |||
Clinical response | 0.29 | |||||
 ⩾50% | 343 | 74 (69–79) | 1 | |||
 <50% | 127 | 67 (58–77) | 1.2 (0.8–1.8) | |||
Locoregional treatment | <10−3 | |||||
 Postop | 308 | 77 (71–83) | ||||
 Preop/excl | 168 | 61 (53–70) | 2.0 (1.4–2.8) |